A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...
Intellia Therapeutics (NASDAQ:NTLA) management used its fourth-quarter and full-year 2025 earnings call to highlight progress ...
ERS Genomics Limited ('ERS'), the CRISPR licensing company, today announced the launch of its Early Access Express License, a ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...
KLF5 appears to fuel pancreatic cancer metastasis by reprogramming epigenetic controls, offering a potential new therapeutic target.
Researchers used genome-wide CRISPR screens to identify genetic diseases responsive to vitamins B2 and B3. In mice lacking ...
In the first State of the Union address of his second term, President Donald Trump played the health care hits, touting ...
By the 1890s, just as the medical world was beginning to understand that invisible microbes caused infectious diseases, the idea that a missing ...
CAMBRIDGE, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing ...
Support vector machines improve classification by mapping inseparable signals into higher-dimensional spaces. Random forest models, through ensemble decision trees, increase robustness against ...
Scientists at Gladstone Institutes have flipped the traditional approach to finding potential treatments for deadly diseases. Instead of starting with a disease and hunting for a cure, they began with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results